Melatonin versus Zinc for Sleep Disorders in Cirrhotic Patients: A Randomized Double-Blind Pilot Trial Melatonin or zinc in sleep disorders of cirrhosis
Iranian Journal of Pharmaceutical Sciences,
Vol. 22 No. 1 (2026),
26 Bahman 2026
,
Page 25-30
https://doi.org/10.22037/ijps.v22i1.50731
Abstract
Given the absence of an established gold standard for managing sleep disturbances in patients with cirrhosis, the present randomized double-blind trial was conducted to evaluate the efficacy and safety of melatonin (5 mg/night) versus zinc (50 mg/night) in alleviating sleep disorders within this population. A total of 42 eligible participants were enrolled and randomly assigned to receive either melatonin or zinc. The Pittsburgh Sleep Quality Index (PSQI) was evaluated at baseline and again after one month of treatment. All participants tolerated the interventions well, and no dropouts occurred during the study period. Statistical analysis revealed that PSQI scores significantly improved in both treatment groups compared with baseline (p = 0.001 for both the melatonin and zinc groups). However, there was no statistically significant difference between the two interventions in PSQI scores at the end of the trial (p = 0.936). Based on the observed efficacy and tolerability, both melatonin at 5 mg nightly and zinc at 50 mg nightly may be considered as viable options for addressing sleep disorders in individuals with cirrhosis.
- Melatonin
- Zinc
- Sleep disorder
- Cirrhosis
- Clinical trial
How to Cite
References
1. Bruyneel M, Sersté T. Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges. Nat Sci Sleep. 2018; 2; 10:369-375
2. Hui Y, Chen X, Sun Ch. Sleep disturbances in patients with cirrhosis: Pursuing just right. Portal hypertension and cirrhosis 2024; 2:181-191
3. Shahrokh S, Namazi N, Abbasinazari M, Abazarikia A, Sadeghi A, Mahboubi A. Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome. Iran J Pharm Res. 2025; 15;24:e156425.
4. Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. On the origin and the consequences of circadian abnormalities in patients with cirrhosis. Am J Gastroenterol. 2010; 105:1773–1781.
5. De Silva AP, Niriella MA, Ediriweera DS, De Alwis JP, Liyanage IK, Ettickan U, Liyanapathirana KV, Undugodage C, de Silva HA, de Silva HJ. Low-dose melatonin for sleep disturbances in early-stage cirrhosis: A randomized, placebo-controlled, cross-over trial. JGH Open. 2020; 18;4:749-756.
6. Chan V and Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgrad Med J 2022; 98: 285–293.
7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019; 70:172-193
8. Jazinaki MS, Gheflati A, Moghadam MRSF, Hadi S, Razavidarmian M, Nezhad MY, Akhtari H, Nematizadeh M, Safarian M. Effects of zinc supplementation on sleep quality in humans: A systematic review of randomized controlled trials. Health Sci Rep. 2024; 6; 7:e70019
9. Zhang Z, Hui Y, Yang W, Guo G, Cui B, Li C, Wang X, Fan X, Sun C. Association between serum trace elements and sleep disturbance in patients with decompensated cirrhosis. Ther Adv Chronic Dis. 2023; 18; 14:20406223231192829
10. Nazari MA, Malayeri SH, Pourhoseingholi MA, Mohebi SR, Zali MR. Evaluation of Zinc Plasma Level in Iranian Cirrhotic Patients due to Hepatitis B and Hepatitis C. Hepat Mon. 2010;10:62-4.
11. Grønbæk L, Watson H, Vilstrup H, Jepsen P. Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites. United European Gastroenterol J. 2018; 6:407-412.
12. Vaziri N, Shakourifar M, Sattari P, Sadeghi A, Sharifi M, Moghadas A, Moghaddas A. Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial. Iran J Pharm Res. 2025; 6; 23:e156581.
13. Farrokhian A, Tohidi M, Ahanchi N S, Khalili D, Niroomand M, et al. Effect of Bedtime Melatonin Administration in Patients with Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial.Iran J Pharm Res.2019;18:e124689
14. Zeng L, Zhang L. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review. Trop Med Int Health. 2011; 16:1474-82
15. Lavoie CJ, Zeidler MR, Martin JL. Sleep and aging. Sleep Science Practice 2018; 2:3
16. Grigoriou I, Kotoulas S-C, Porpodis K, Spyratos D, Papagiouvanni I, Tsantos A, Michailidou A, Mourelatos C, Mouratidou C, Alevroudis I, et al. The Interactions between Smoking and Sleep. Biomedicines. 2024; 12:1765.
17. Harman H, Serpek B. The Effect of Zinc Supplementation on Plasma Melatonin and Kisspeptin Levels in Rams. Livestock Studies. 2022; 62:31-6.
18. Ali M, Aziz T. The Combination of Zinc and Melatonin Enhanced Neuroprotection and Attenuated Neuropathy in Oxaliplatin-Induced Neurotoxicity. Drug Des Devel Ther. 2022; 4; 16:3447-3463
19. Darchia N, Oniani N, Sakhelashvili I, Supatashvili M, Basishvili T, Eliozishvili M, Maisuradze L, Cervena K. Relationship between Sleep Disorders and Health Related Quality of Life-Results from the Georgia SOMNUS Study. Int J Environ Res Public Health. 2018; 26;15:1588.
- Abstract Viewed: 269 times
- IJPS_Volume22_Issue1_Pages25-30 Downloaded: 144 times